Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Conditions

• Carcinoma, Renal Cell
• Melanoma

Interventions

• BIOLOGICAL: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody
• BIOLOGICAL: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody
• BIOLOGICAL: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody
• BIOLOGICAL: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody
• BIOLOGICAL: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody
• BIOLOGICAL: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody
• BIOLOGICAL: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ ) Monoclonal Antibody
• BIOLOGICAL: GC1008 Human Anti Transforming Growth Factor _Beta (TGFβ) Monoclonal Antibody

Sponsor

Genzyme, a Sanofi Company